Rosetta Genomics

/C O R R E C T I O N -- Rosetta Genomics Ltd/ (PR Newswire)

yahoo.com
Nov 6, 2008 2 related
        

Thursday November 6, 10:39 am ET In the news release, "Rosetta Genomics to Present at Rodman & Renshaw 10th Annual Healthcare Conference" issued on 5 Nov 2008 13:30 GMT, by Rosetta Genomics Ltd nasdaq:ROSG over PR Newswire, we...

add comment

Rosetta Genomics to Present at Rodman & Renshaw 10th Annual Healthcare Conference (PR Newswire)

yahoo.com
Nov 5, 2008 1 related
        

Rosetta Genomics Ltd. , a leader in the development of microRNA-based diagnostics, announced today it will present at the Rodman & Renshaw 10th Annual Healthcare Conference on Wednesday, November 10 at The New York Palace Hotel...

add comment

Rosetta Genomics Launches Plant Biotech Initiative

isaaa.org
Nov 1, 2008
        

Israel-based Rosetta Genomics Ltd. announced that it will enter the field of plant biotechnology with the launch of its Rosetta Green initiative. In a press release, the company said that Rosetta Green will leverage the...

add comment

Rosetta recovers ARS

globes.co.il
Oct 28, 2008
        

Credit Suisse will buy back $7.5 million worth of ARS. Rosetta Genomics Ltd. (Nasdaq:ROSG ) is the fifth Israeli company to reach a settlement with Credit Suisse on Auction Rate Securities (ARS) investments made on its behalf....

add comment

Rosetta Genomics Launches Plant Biotech Initiative to Leverage microRNA Technologies; Potential...

alternative-energy-news.info
Oct 28, 2008
        

Rosetta Genomics Ltd., a leading developer of microRNA-based diagnostics and therapeutics, has launched Rosetta Green, a microRNA-based plant biotechnology project. Rosetta Green will leverage the knowledge gained at Rosetta...

add comment

Rosetta Genomics Launches MicroRNA-Based Plant Biotechnology Project

azonano.com
Oct 28, 2008
        

Rosetta Genomics Ltd , a leading developer of microRNA-based diagnostics and therapeutics, announced today it has launched Rosetta Green, a microRNA-based plant biotechnology project. Rosetta Green will leverage the extensive...

add comment

BRIEF-Credit Suisse repurchases ARS from Rosetta Genomics

finanznachrichten.de
Oct 28, 2008
        

Oct 27 (Reuters) - Oct 27 (Reuters) - Rosetta Genomics Ltd: repurchases auction rate securities from Rosetta Genomics * Says Credit Suisse has repurchased $2.7 million worth of the $7.5 million in ARS held by Rosetta Genomics *...

add comment

Credit Suisse Repurchases Auction Rate Securities (ARS) From Rosetta Genomics (PR Newswire)

yahoo.com
Oct 27, 2008
        

Rosetta Genomics Ltd. , a leader in the development of microRNA-based diagnostics and therapeutics, today announced that Credit Suisse, as part of a settlement agreement it has reached with the Attorney General of the State of...

add comment

Rosetta Genomics Leverages its MicroRNA Platform Technologies to Launch Plant Biotech Initiative...

yahoo.com
Oct 27, 2008
        

Monday October 27, 8:56 am ET - Initiates Rosetta Green, a Project Which Will Leverage RosettaGenomics' Proprietary microRNA Technologies and Strong IP Position to Developa Wide Range of Plant-Based Applications- Rosetta has...

add comment

Credit Suisse Repurchases Auction Rate Securities (ARS) From Rosetta Genomics

finanznachrichten.de
Oct 27, 2008
        

REHOVOT, Israel and JERSEY CITY, New Jersey, October 27 /PRNewswire/ -- Rosetta Genomics Ltd. (Nasdaq:ROSG), a leader in the development of microRNA-based diagnostics and therapeutics, today announced that Credit Suisse, as...

add comment